Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis by Pardanani, Animesh, Tefferi, Ayalew, Masszi, Tamás, Mishchenko, Elena, Drummond, Mark, Jourdan, Eric, Vannucchi, Alessandro, Jurgutis, Mindaugas, Ribrag, Vincent, Rambaldi, Alessandro, Koh, Liang Piu, Rose, Shelonitda, Zhang, Jun, Harrison, Claire

Get full text

Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF): Updated Results from the Randomized, Placebo-Con... by Pardanani, Animesh, Tefferi, Ayalew, Masszi, Tamas, Mishchenko, Elena, Drummond, Mark W., Jourdan, Eric, Vannucchi, Alessandro M., Jurgutis, Mindaugas, Ribrag, Vincent, Rambaldi, Alessandro, Koh, Liang Piu, Rose, Shelonitda, Zhang, Jun, Harrison, Claire

Get full text

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study by Mohty, Mohamad, Lejniece, Sandra, Beksac, Meral, Bekadja, Mohamed Amine, Stankovic, Svetlana, De Stefano, Valerio, Kochkareva, Yulia, Laane, Edward, Salwender, Hans, Masliak, Zvenyslava, Silva, João, Louw, Vernon, Abadi, Uri, Couturier, Catherine, Feys, Caroline, Thoret-Bauchet, Florence, Bekadja, Mohamed, Ali, Hocine Ait, Hamdi, Selma, Touhami, Hadj, Pedersen, Robert Shou, Laane, Edward, Hein, Marju, Moreau, Philippe, Cartron, Guillaume, Dine, Gérard, Harich, Hanns-Detlev, Illmer, Thomas, Dörfel, Steffen, Koenigsmann, Michael, Schlag, Rudolf, Uhlig, Jens, Schütz, Stefan, Tessen, Hans-Werner, Mohr, Benno, Heinrich, Bernhard, Von Weikersthal, Ludwig Fischer, Heßling, Jörg, Schauer, Michael, Dürk, Heinz, Hess, Georg, Matsouka, Panagiota, Ivanyi, Janos, Abadi, Uri, Avivi, Irit, Foa, Roberto, Corso, Alessandro, Ferrara, Felicetto, Cantonetti, Maria, Di Raimondo, Francesco, Pizzuti, Michele, Farina, Gabriella, La Nasa, Giorgio, Cangialosi, Clotilde, Federici, Augusto, Romano, Atelda, Specchia, Giorgina, Latte, Giancarlo, Mannina, Donato, Pečeliūnas, Valdas, Jurgutis, Mindaugas, Stankovic, Svetlana, Homenda, Wojciech, Starzak-Gwozdz, Jolanta, Komarnicki, Mieczyslaw, Gonçalves, Cristina, Esefyeva, Natalia, Kochkareva, Julia, Kaplanov, Kamil, Laricheva, Elena, Dergacheva, Valentina, Nazarova, Irina, Anchukova, Ludmila, Ovanesova, Elena, Gritsenko, Taras, Kuznetsova, Irina, Osyunikhina, Svetlana, Serdyuk, Olga, Karyagina, Elena, Ivanova, Valentina, Gutiérrez, Asunción Echeveste, Capote, Francisco Javier, Sanchez, Jesus Martin, Ibañez-Garcia, Jeronima, Herranz, Maria Jose, Sanchez, Sara Sanchez, Lleonart, Joan Bargay, Martínez, Rafael, De La Serna, Javier, Mateos, Maria-Victoria, Beksac, Turkey – Meral, Aydin, Yildiz, Bilgir, Oktay, Ali, Ridvan, Kyselyova, Maryna, Dyagil, Iryna, Yushchenko, Natalia, Kozlov, Viktor, Harousseau, Jean-Luc, De la Rubia, Javier

Get full text

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential th... by Gisslinger, Heinz, Buxhofer‐Ausch, Veronika, Hodisch, Juri, Radinoff, Atanas, Karyagina, Elena, Kyrcz‐Krzemień, Slawomira, Abdulkadyrov, Kudrat, Gerbutavicius, Rolandas, Melikyan, Anait, Burgstaller, Sonja, Hus, Marek, Kłoczko, Janusz, Yablokova, Vera, Tzvetkov, Nikolay, Całbecka, Malgorzata, Shneyder, Tatyana, Warzocha, Krzysztof, Jurgutis, Mindaugas, Kaplanov, Kamil, Jilma, Bernd, Schoergenhofer, Christian, Klade, Christoph

Get full text

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013 by Beinortas, Tumas, Tavorienė, Ilma, Žvirblis, Tadas, Gerbutavičius, Rolandas, Jurgutis, Mindaugas, Griškevičius, Laimonas

Get full text

Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia by Pileckyte, Regina, Jurgutis, Mindaugas, Valceckiene, Vilma, Stoskus, Mindaugas, Gineikiene, Egle, Sejoniene, Jurgita, Degulys, Andrius, Zvirblis, Tadas, Griskevicius, Laimonas

Get full text

Symptom Burden and Health-Related Quality Of Life (HRQoL) In Patients With Myelofibrosis (MF) Treated With Fedratinib (SAR302503) In a Phase III Study (JAKARTA) by Mesa, Ruben A., Cortes, Jorge E., Cervantes, Francisco, Milligan, Donald, Masszi, Tamás, Mishchenko, Elena, Jourdan, Eric, Vannucchi, Alessandro M., Drummond, Mark, Jurgutis, Mindaugas, Kuliczkowski, Kazimierz, Gheorghita, Emanuil, Passamonti, Francesco, Neumann, Frank, Joulain, Florence, Iqbal, Sheikh Usman, Harrison, Claire N

Get full text

Results Of a Randomized, Double-Blind, Placebo-Controlled Phase III Study (JAKARTA) Of The JAK2-Selective Inhibitor Fedratinib (SAR302503) In Patients With Myelofibrosis (MF) by Pardanani, Animesh, Harrison, Claire N, Cortes, Jorge E., Cervantes, Francisco, Mesa, Ruben A., Milligan, Donald, Masszi, Tamás, Mishchenko, Elena, Jourdan, Eric, Vannucchi, Alessandro M., Drummond, Mark, Jurgutis, Mindaugas, Kuliczkowski, Kazimierz, Gheorghita, Emanuil, Passamonti, Francesco, Neumann, Frank, Gao, Guozhi, Tefferi, Ayalew

Get full text

Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia by Griskevicius, Laimonas, Stulpinas, Rokas, Vengalyte, Indre, Saulyte-Trakymiene, Sonata, Mickys, Ugnius, Pranys, Darius, Kurtinaitis, Juozas, Jurgutis, Mindaugas

Get full text